α 2(VIII) collagen substrata enhance endothelial cell retention under acute shear stress flow via an α 2β 1 integrin-dependent mechanism: An in vitro and in vivo study

Circulation

Volumn 114, Issue 8, 2006, Pages 820-829

  Turner, Neill J ^a,b,d   Murphy, Michael O ^a,b,d   Kielty, Cay M ^a,b,e   Shuttleworth, C Adrian ^e   Black, Richard A ^a,c   Humphries, Martin J ^e   Walker, Michael G ^a,b,d   Canfield, Ann E ^a,b,e,f  

^a UK Centre for Tissue Engineering   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cell adhesion molecules; Collagen; Endothelium; Integrins; Vascular grafts

Indexed keywords

ANTIBODY; ARGINYLGLYCYLASPARTIC ACID; COLLAGEN TYPE 8; COLLAGEN TYPE 8 ALPHA2; FIBRONECTIN; POLYURETHAN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; COL8A2 PROTEIN, HUMAN; INTEGRIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD VESSEL GRAFT; CAROTID ARTERY; CELL ACTIVITY; CELL ADHESION; COMPOSITE GRAFT; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GOAT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; ANIMAL; ANIMAL MODEL; GENETICS; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; COLLAGEN TYPE VIII; ENDOTHELIUM, VASCULAR; FEMALE; GOATS; HUMANS; INTEGRIN ALPHA2BETA1; INTEGRINS; MODELS, ANIMAL; POLYURETHANES; RECOMBINANT PROTEINS; STRESS, MECHANICAL;

EID: 33747610932     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.635292     Document Type: Article

References (41)

1. Ballermann BJ, Dardik A, Eng E, Liu A. Shear stress and the endothelium. Kidney Int. 1998;54:s100-s108.
2. Rosenman JE, Kempczinski RF, Pearce WH, Silberstein EB. Kinetics of endothelial cell seeding. J Vasc Surg. 1985;2:778-784.
3. Baguneid M, Murray D, Salacinski HJ, Fuller B, Hamilton G, Walker M, Seifalian AM. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem. 2004;39(pt 2):151-157.
4. Pu FR, Williams RL, Markkula TK, Hunt JA. Effects of plasma treated PET and PTFE on expression of adhesion molecules by human endothelial cells in vitro. Biomaterials. 2002;23:2411-2428.
5. Miller DC, Webster TJ, Haberstroh KM. Technological advances in nanoscale biomaterials: the future of vascular graft design. Expert Rev Med Devices. 2004;1:259-268.
6. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg. 2001;71(suppl):S327-S331.
7. Vohra R, Thomson GJ, Carr HM, Sharma H, Walker MG. Comparison of different vascular prostheses and matrices in relation to endothelial seeding. Br J Surg. 1991;78:417-420.
8. Desgranges P, Tardieu M, Loisance D, Barritault D. Extracellular matrix covered biomaterials for human endothelial cell growth. Int J Artif Organs. 1992;15:722-726.
9. Bujan J, Garcia-Honduvilla N, Bellon JM. Engineering conduits to resemble natural vascular tissue. Biotechnol Appl Biochem. 2004;39(pt 1):17-27.
10. Sage H, Pritzl P, Bornstein P. A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture. Biochemistry. 1980;19:5747-5755.
11. Shuttleworth CA. Type VIII collagen. Int J Biochem Cell Biol. 1997;29:1145-1148.
12. Kittelberger R, Davis PF, Greenhill NS. Immunolocalization of type VIII collagen in vascular tissue. Biochem Biophys Res Commun. 1989;159:414-419.
13. Greenhill NS, Ruger BM, Hasan Q, Davis PF. The alpha1(VIII) and alpha2(VIII) collagen chains form two distinct homotrimeric proteins in vivo. Matrix Biol. 2000;19:19-28.
14. Sage H, Iruela-Arispe ML. Type VIII collagen in murine development: association with capillary formation in vitro. Ann N Y Acad Sci. 1990;580:17-31.
15. Iruela-Arispe ML, Sage EH. Expression of type VIII collagen during morphogenesis of the chicken and mouse heart. Dev Biol. 1991;144:107-118.
16. Sinha S, Kielty CM, Heagerty AM, Canfield AE, Shuttleworth CA. Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis. Int J Exp Pathol. 2001;82:295-302.
17. Saelman EU, Nieuwenhuis HK, Hese KM, de Groot PG, Heijnen HF, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood. 1994;83:1244-1250.
18. Turner NJ, Kielty CM, Walker MG, Canfield AE. A novel hyaluronan-based biomaterial (Hyaff-11) as a scaffold for endothelial cells in tissue engineered vascular grafts. Biomaterials. 2004;25:5955-5964.
19. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
20. Humphries MJ. Cell adhesion assays. Mol Biotechnol. 2001;18:57-61.
21. Tuckwell DS, Smith L, Korda M, Askari JA, Santoso S, Barnes MJ, Farndale RW, Humphries MJ. Monoclonal antibodies identify residues 199-216 of the integrin alpha2 vWFA domain as a functionally important region within alpha2beta1. Biochem J. 2000;350:485-493.
22. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol. 1989;109:863-875.
23. Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science. 1995;267:883-885.
24. Rashid ST, Salacinski HJ, Hamilton G, Seifalian AM. The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials. 2004;25:1627-1637.
25. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater. 2005;74:570-581.
26. Bernacca GM, Gulbransen MJ, Wilkinson R, Wheatley DJ. In vitro blood compatibility of surface-modified polyurethanes. Biomaterials. 1998;19:1151-1165.
27. Aldenhoff YB, Koole LH. Platelet adhesion studies on dipyridamole coated polyurethane surfaces. Eur Cell Mater. 2003;5:61-67.
28. Ben Hamida F, M'hibik S, Karoui C, Abderrahim E, Kaaroud H, Beji S, Zouaghi K, Barbouche S, Goucha R, Hedri H, El Younsi F, Ben Abdallah T, Ben Moussa F, Kheder A, Ben Maiz H. Indications, complications and cost of internal jugular catheters in hemodialysed patients: study of 533 cases [in French]. Tunis Med. 2005;83:519-523.
29. Chan BP, Liu W, Klitzman B, Reichert WM, Truskey GA. In vivo performance of dual ligand augmented endothelialized expanded polytetrafluoroethylene vascular grafts. J Biomed Mater Res B Appl Biomater. 2005;72:52-63.
30. Tiwari A, Salacinski HJ, Punshon G, Hamilton G, Seifalian AM. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J. 2002;16:791-796.
31. Jun HW, West J. Development of a YIGSR-peptide-modified polyurethaneurea to enhance endothelialization. J Biomater Sci Polym Ed. 2004;15:73-94.
32. Fernandez P, Deguette A, Pothuaud L, Belleannee G, Coste P, Bordenave L. Quality control assessment of ePTFE precoating procedure for in vitro endothelial cell seeding. Biomaterials. 2005;26:5042-5047.
33. Berger K, Sauvage IR, Rao AA, Wood S. Healing of arterial prostheses in man: its incompleteness. Ann Surg. 1972;175:119-127.
34. Stephan S, Sherratt MJ, Hodson N, Shuttleworth CA, Kielty CM. Expression and supramolecular assembly of recombinant alpha1(viii) and alpha2(viii) collagen homotrimers. J Biol Chem. 2004;279:21469-21477.
35. Illidge C, Kielty C, Shuttleworth A. The alpha1(VIII) and alpha2(VIII) chains of type VIII collagen can form stable homotrimeric molecules. J Biol Chem. 1998;273:22091-22095.
36. Tulla M, Pentikainen OT, Viitasalo T, Kapyla J, Impola U, Nykvist P, Nissinen L, Johnson MS, Heino J. Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains. J Biol Chem. 2001;276:48206-48212.
37. Ruegg C, Dormond O, Mariotti A. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis. Biochim Biophys Acta. 2004;1654:51-67.
38. Iivanainen E, Kahari VM, Heino J, Elenius K. Endothelial cell-matrix interactions. Microsc Res Tech. 2003;60:13-22.
39. Luckman SP, Rees E, Kwan AP. Partial characterization of cell-type X collagen interactions. Biochem J. 2003;372:485-493.
40. Hou G, Mulholland D, Gronska MA, Bendeck MP. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am J Pathol. 2000;156:467-476.
41. Siljander PR, Hamaia S, Peachey AR, Slatter DA, Smethurst PA, Ouwehand WH, Knight CG, Farndale RW. Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem. 2004;279:47763-47772.